UBE2C and cholangiocarcinoma: We observed that the low-stage cholangiocarcinoma tumor tissues had weak UBE2C expression (Fig. 2A–D), whereas the high-stage cholangiocarcinoma tumor tissues had strong UBE2C expression (Fig. 2E–H).